Advanced Search
Displaying assets from 1 to 30 out of 3
-
Description Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levelsa According to the Polymorphism in Both Groups of Patients Studied During the Pregnancy and at Baseline
Article Title: ORIGINAL ARTICLE: Thrombin Activatable Fibrinolysis Inhibitor and Clot Lysis Time in Pregnant Patients with Antiphospholipid Syndrome: Relationship with Pregnancy Outcome and Thrombosis
Publication Title: American Journal of Reproductive Immunology -
Description Distribution of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Polymorphisms in Both Groups of Patients Studied
Article Title: ORIGINAL ARTICLE: Thrombin Activatable Fibrinolysis Inhibitor and Clot Lysis Time in Pregnant Patients with Antiphospholipid Syndrome: Relationship with Pregnancy Outcome and Thrombosis
Publication Title: American Journal of Reproductive Immunology -
Description Clinical Characteristics and Pregnancy Outcome
Article Title: ORIGINAL ARTICLE: Thrombin Activatable Fibrinolysis Inhibitor and Clot Lysis Time in Pregnant Patients with Antiphospholipid Syndrome: Relationship with Pregnancy Outcome and Thrombosis
Publication Title: American Journal of Reproductive Immunology